Clinical Trials Directory

Trials / Unknown

UnknownNCT04971434

Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping

Non-alcoholic Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping-with-scarification

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
35 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Every-two-week applied cupping (with scarification) session within one month on back of upper thorax is not compared previously regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) in fatty liver patients. This trial will compare the two procedure effects on cardio-metabolic risk factors in fatty liver.

Detailed description

In fatty liver patients,every-two-week applied cupping (with scarification) session within one month on back of upper thorax for 30 patients will be compared regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) of other 30 patients.

Conditions

Interventions

TypeNameDescription
DEVICElaser stimulation for acupointsIn fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9,12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian
OTHERcupping with scarificationIn fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax

Timeline

Start date
2021-07-11
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2021-07-21
Last updated
2021-07-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04971434. Inclusion in this directory is not an endorsement.